Shares of Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report) passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.01 and traded as low as $0.0081. Evofem Biosciences shares last traded at $0.0096, with a volume of 497,411 shares.
Evofem Biosciences Stock Performance
The company has a 50 day simple moving average of $0.01 and a 200 day simple moving average of $0.01. The company has a market capitalization of $1.22 million, a PE ratio of -0.02 and a beta of -1.12.
Evofem Biosciences Company Profile
Evofem Biosciences, Inc, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.
Featured Articles
- Five stocks we like better than Evofem Biosciences
- What is the MACD Indicator and How to Use it in Your Trading
- 3 Beaten-Down Stocks With Rebound Potential This Earnings Season
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Amazon Is One of the Clearest Buys If the Market Dips Again
- There Are Different Types of Stock To Invest In
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
